FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Comments Sought on Pediatric Drug Safety Reviews

[ Price : $8.95]

Federal Register notice: FDA seeks comments related to post-marketing pediatric-focused safety reviews of products posted between ...

Panel to Review Makena Unfavorable Study

[ Price : $8.95]

Federal Register notice: FDA announces a 10/29 advisory committee meeting to review an Amag Pharma confirmatory clinical trial tha...

MAPP on Patient-Oriented Labeling Consults

[ Price : $8.95]

CDER issues a MAPP with procedures to be followed when its Division of Medication Error Prevention consults its Division of Medica...

Dietary Supplement CGMP Violations at Nutra Solutions

[ Price : $8.95]

FDA warns Nutra Solutions about CGMP violations in its work as a contract manufacturer of dietary supplements.

FTC Questions Ads for Drug Company Lawsuits

[ Price : $8.95]

FTC warns seven unidentified legal practitioners and lead generators that TV ads soliciting clients to sue drug companies may be d...

AveXis Fires 2 Execs for Data Manipulation

[ Price : $8.95]

AveXis tells FDA it has terminated two senior executives who were the subject of a company investigation into data manipulation fo...

FDA OKs Cardiovascular Systems ViperWire

[ Price : $8.95]

FDA approves a Cardiovascular Systems PMA for its ViperWire Advance Coronary Guide Wire with Flex Tip.

Final Guide for ALS Drug Development

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Amyotrophic Lateral Sclerosis (ALS): Developing Drugs for T...

Clinical Hold on Abeona Gene Therapy

[ Price : $8.95]

FDA places a clinical hold on an Abeona Therapeutics planned Phase 3 clinical trial for EB-101 until it submits additional data po...

Oncologists Respond Swiftly to FDA Safety Alerts: Study

[ Price : $8.95]

Researchers say oncologists can move quickly when FDA issues new safety information on therapies approved under accelerated approv...